Patient-reported Outcomes of Cemiplimab versus Chemotherapy in Advanced NSCLC: PD-L1 Level Subgroups in EMPOWER-Lung 1

Kilickap, S.Sezer, A.Gumus, M.Bondarenko, I.Ozguroglu, M.Gogishvili, M.He, X.Gullo, G.Rietschel, P.Quek, R. G.2022-11-042022-11-0420221556-0864http://hdl.handle.net/11727/8004enginfo:eu-repo/semantics/closedAccessPatient-reported Outcomes of Cemiplimab versus Chemotherapy in Advanced NSCLC: PD-L1 Level Subgroups in EMPOWER-Lung 1Conference Object179125126000858678100196